DEA Classification Change for Tramadol

Tramadol (brand name Ultram) is a centrally-acting “opioid-like” analgesic. It was approved by the FDA in 1995.  Since then, generic, combination, and extended release formulations have also been approved.   Per the PMSI 2013 Annual Drug Trends Report for Workers’ Compensation, tramadol (brand name Ultram and Ultram ER) was ranked number 3 under the top 20 medications … Read moreDEA Classification Change for Tramadol

DEA Classification Change for Carisoprodol

What is Carisoprodol? Carisoprodol (brand name Soma) is a skeletal muscle relaxant approved by the FDA for use in painful musculoskeletal conditions on an acute basis.  When the 350mg strength dosage was approved 53 years ago, the medication was classified as a non-controlled, non-scheduled drug.  However, on December 12, 2011 the DEA ruled under the … Read moreDEA Classification Change for Carisoprodol